Launch of European Coalition on Sex Workers’ Rights and Inclusion: Public Statement

We are proud to be one of the 15 organisations making up the European Coalition on Sex Workers’ Rights and Inclusion.

After the first European Sex Workers Alliance (ESWA) congress, a joint statement has been released announcing the launch of the new coalition aiming to end the criminalisation of sex work, protect sex workers from mass surveillance, include sex workers in the development and evaluation of laws, support the self organisation of sex workers, and to fund and support sex workers’ organisations and evidence based and person-centered policy-making.

“The organisations who make up the Coalition are: Aids Action Europe (AAE), Amnesty International, Correlation European Harm Reduction Network (Correlation EHRN), European Aids Treatment Group (EATG), European Digital Rights (EDRi), European Network Against Racism (ENAR), European Sex Workers’ Rights Alliance (ESWA), Equinox – Racial Justice Initiative, Fair Trials, Human Rights Watch, International Planned Parenthood Federation European Network (IPPF EN), International Lesbian, Gay, Bisexual, Trans and Intersex Association Europe (ILGA-Europe), La Strada International (LSI), Platform for International Cooperation on Undocumented Migrants (PICUM), and Transgender Europe (TGEU).”

We are proud to stand in solidarity with sex workers, sex worker rights defenders, and their organisations. We hope this joint statement helps implement the change which is urgently required.

For any information please contact info@eswalliance.org.

Insights from INHSU Policy Day

C-EHRN’s policy officer Roberto Perez presented the latest developments in drug consumption rooms (DCRs) at the INHSU2022 policy event.

During the presentation, the following developments were addressed;

When looking at the diversity of needs of people who use drugs, Roberto addressed topics of homelessness, safer spaces for women and people of diverse SOGIESC, and broadening accessibility. Drug checking, “Challenging” substances and law enforcement innovations were presented as developments in increasing the safety of people who use drugs in this context. Finally, Roberto discussed real time insights and implementation research as ways of monitoring and research.

“DCRs are a local response to local needs, values, communities, lived experiences, histories & resources.”

Abstract Submission Open for LEPH 2023

Participate in the LEPH2023 Conference by submitting an abstract for a conference presentation.

LEPH is a conference exploring the complex and diverse intersections of law enforcement and public health; involving practitioners, policy makers and researchers from these and other related sectors.

LEPH2023 Europe will provide a major opportunity to further develop our understanding of the intersections between police and other law enforcement personnel and those individuals and organisations delivering public health programs in the community, and how to strengthen and sustain them. The key theme for LEPH2023 Europe is ‘Together towards resilient communities’, building on previous LEPH conferences which have described and analysed the issues, examined a huge range of actual and possible responses globally, and stressed the importance of collaborative leadership in policy and practice.

The conference offers a safe space to address such questions as:

IMPORTANT DATES

Drug Policy Executive Course – 2023

After the success of the Drug Policy Executive Course conducted in 2021-2022, the International Drug Policy Academy is now launching the second edition of this advance comprehensive course to be held in 2023. 

Drug Policy Executive Course is a three-module advanced course over a 12-month period, with in-person and distant learning components. The course will lead to a Certificate in Advance Drug Policy Management delivered by the International Drug Policy Academy. It is specially designed for managers or senior team members working in the area of drug policies and addictions. The Drug Policy Executive Course contains all key competency areas related to drug policy development, implementation, and evaluation.

The course aims to allow knowledge transfer among experienced professionals willing to expand their competences in this unique atmosphere.

If you are interested to be part of the graduates of this unique course – enrolment is open only till 15 November 2022. Should you have any questions or require further information, feel free in contacting the Secretariat at Pompidou.Academy@coe.int.

Call for Youth Voices

Are you between 16 and 29 years old? Do you live in Europe or central Asia? For the #Youth4Health Tirana 2022 Health and Well-being Forum for Youth, we are calling young people to submit short clips.

We want to hear from you on the following questions:
Youth engagement
  • Why is it important to engage youth in health and well-being decision-making?
  • How would you ensure that youth is involved in decision-making to build a better, healthier future?
  • What do you want doctors and policymakers to know about young people’s health and well-being that they forget or often do not understand?
  • What else would you like to share?
Youth health 
  • What health issues matter most to you?
  • What inspires and enables you to look after your health and well-being?
COVID-19
  • How has the COVID-19 pandemic impacted on your life? 
  • What helped you to cope during the pandemic?
How to record:
  • Choose one question and record about 20-30 seconds 
  • Record with your phone or laptop in landscape format
  • You can submit videos for multiple questions
  • Please share in the highest resolution possible
Deadline: 18 September 2022
The clips will be shown at the #Youth4Health Tirana 2022 Youth and Well-being Forum, in Tirana (Albania) on 25-27 October 2022 and on WHO and its partners’ web and social media channels.

Joint Statement on Operating Grants for Health NGOs

Correlation have contributed to a joint statement regarding operating grants for health NGOs, and what changes need to be made to support the work we are doing.

Operating Grants are crucial for health NGOs to continue playing their essential role in EU policymaking processes. While Operating Grants were reinstated and their value recognized within the EU4Health Work Programme 2022, so far, there is no formal commitment to continue this vital source of funding beyond 2022. In September 2022, this lack of visibility leaves health NGOs with serious concerns for their long-term sustainability and capacity to play their role, and, for some, with concerns over their very survival.

As we wait for the publication of the EU4Health 2023 Work Programme, members of the EU4Health Civil Society Alliance call on the European Commission to include Operating Grants for health NGOs in the 2023 Work Programme. We are also calling for Operating Grants to be reinstated through a multi-annual process to ensure better and timelier strategic planning.

Our organisations call on the European Commission to include Operating Grants as a financing mechanism to provide a strong foundation for the contribution of health NGOs as part of the 2023 Work Programme and beyond.

Civil Society Demands Balanced EU Funding for Drug Policies

Civil society organisations sent an open letter to the EU Commission to criticise the new call for drug policy grant proposals that almost only focuses on law enforcement and excludes harm reduction.

C-EHRN sent an open letter to Ilva Johanson, Commissioner of Home Affairs, and Floriana Sipala, the head of the Drug Unit of the EC, to address this issue. The text of the open letter:

“We write to you on behalf of Correlation – European Harm Reduction Network (C-
EHRN), representing 158 civil society organisations (CSO) working in the area of harmreduction drug policy in Europe. C-EHRN is part of Foundation De Regenboog Groep
and, as such, is also represented in the EU Civil Society Forum on Drugs.

Together with the undersigned networks, we would like to express our concern and
disappointment with the current call of the Internal Security Grant concerning better
law enforcement in the area of illicit drug trafficking. We believe this call does not
reflect the principles of an evidence-based, integrated, balanced and multidisciplinary
approach to the drugs phenomenon and is not in line with the Drug Strategy of the
European Union. The call has a narrow focus on law enforcement interventions, with
no objectives to improve complex public health and social services, including harm
reduction.

For several years, the members and organisations we work with have benefited from
the EC JUST Drug Policy grants launched by the European Commission. These
grants demonstrated the balanced, evidence-based and multidisciplinary approach
to drug policies in accordance with the core principles of the European Union. They
provided an excellent opportunity for civil society organisations working in the field of
drugs to cooperate internationally and exchange knowledge and good practices.

When the Drugs Unit was moved from the Justice Department to the Internal Security
Department, civil society organisations were promised that this would not affect the
balanced and multidisciplinary approach to drug policies of the EU Commission.
However, the apparent shift towards law enforcement and crime prevention proves
different – with social and public health aspects slipping off the agenda.

The Internal Security call lays only limited emphasis on drug demand reduction and
none at all on harm reduction. At the same time, no other EU Programme took over
this responsibility, leaving drug demand and harm reduction behind, without any
opportunity for EU funding and support.

This is an extremely concerning development. EU funding has become increasingly
important in recent years because of the emerging funding crisis for harm reduction,
especially in the Eastern part of the European Union. Since the 2008 economic crisis,
funding for harm reduction has constantly been declining in most Member States.
Several essential services operated by CSOs have been closed down or curtailed due
to budget cuts and the retreat of international donors.

On top of the funding crisis, CSOs experience a shrinking space for civil society in
several Member States, where governments are increasingly hostile to those
organisations that receive international funding or work with marginalised groups of society. With decreasing national and local funds, direct funding from the European
Commission was often the only funding opportunity to improve advocacy and
innovation in the harm reduction field for many organisations. This opportunity is now
lost.

DG Home is the department within the EC responsible for developing and
implementing a balanced, integrated and evidence-based EU Drug Policy. Such a
balanced approach requires that funding mechanisms are available for all drug policy
areas and not only for law enforcement and crime prevention programmes.
We, therefore, call upon the European Commission and DG Home to reinstall the
funding mechanism for drug demand and harm reduction to ensure a balanced and
evidence-based drug policy also in the future.

We look forward to your response and hope for your continued support for civil
society in the area of drug policy and harm reduction.”

Signatory Networks & Organizations:
AIDS Action Europe [AAE]
Drug Policy Network South East Europe [DPNSEE]
EU Civil Society Forum on Drugs1
EU HIV/AIDS, Viral Hepatitis and Tuberculosis Civil Society Forum
Eurasian Harm Reduction Association [EHRA]
European AIDS Treatment Group [EATG]
European Network of People Who Use Drugs [EuroNPUD]
Forum Droghe
Harm Reduction International [HRI]
Federation des Acteurs en Education en Promotion de la Sante de Guyane [AGRRR]
International Drug Policy Consortium [IDPC]
International Network of People Who Use Drugs [INPUD]
MAINline
Positive Voice
Red de Atencion a las Adicciones [UNAD]
ReShape
Youth Organizations for Drug Actions [YODA]

Webinar | Crisis of Harm Reduction Funding

Crisis in Harm Reduction Funding. Opportunities for Governments to act in South-Eastern Europe and the Balkans.

Correlation – European Harm Reduction Network, the Eurasian Harm Reduction Association and the Drug Policy Network of South-Eastern Europe are hosting an online discussion about the funding challenges and opportunities for governments to the crisis of harm reduction services in SEE countries and the Balkans.

The webinar will take place on the 20th of April from 13:00h to 14:30h CET

Countries of South-Eastern Europe and the Balkans, including Albania, Bosnia and Herzegovina, Bulgaria, Kosovo, Montenegro, Romania and Serbia, are experiencing relatively high levels of HIV and HVC infection among people who inject drugs, including those who inject psychoactive substances. However, due to limited domestic resources and the gradual withdrawal of the Global Fund from the region, the governments of these countries are facing a lack of resources to continue the long-term funding of comprehensive harm reduction programmes. In addition to these and other barriers, in some countries, there is no legal basis for NGOs to provide services to marginalized populations, including people who use drugs.

During this webinar, C-EHRN, EHRA and DPNSE will present the research they have conducted in the area and discuss its key findings, which include among others:

Common challenges of scaling-up harm reduction programmes in the countries of South-Eastern Europe.

Consequences of the limited funding of the harm reduction services for public health and national healthcare systems.

Opportunities available for the governments of the region to act and invest funds and efforts in effective and proven models of harm reduction in their respective countries.

 

To register, please fill in the form here https://us02web.zoom.us/webinar/register/WN_-4Dh14MmQumJc3mPJxZgOw

In the meantime, you may access the report here.

C-EHRN Podcast Series #3: How to support broader decriminalisation processes?

Following the 5th European Harm Reduction Conference opening session Drug Policy, Decriminalisation: The next global step for Europe?, we recorded the 2nd episode of C-EHRN Podcast Series. Our guests discussed why there are still too few countries taking the bold step of decriminalisation even though it is proven that it works? 

Why are policymakers still addicted to prohibition, and what steps would be necessary to get them to rehab?

“I think the challenge is how different demographics of the population are involved in electoral politics. Older people with conservative backgrounds are more prominently voting, and younger people feel increasingly disillusioned with politics and struggle to engage. This creates a bias.” said Mat Southwell.

The Drug Policy Reform Session has centred on the decriminalisation of drugs. However, the work of Harm Reduction sits at the intersection of various movements. Many of the communities harm reductionists work with and belong to have also been criminalised through other legal frameworks: e. g. the criminalisation of sex work, migration, sexuality and reproduction (e.g. abortion) or poverty, just to name a few. 

What are mutual aid practices and support across movements still necessary to support broader decriminalisation processes, in your opinion?

Our session guests were Jochen Schroot of VAD – the Flemish centre of expertise on alcohol and other drugs, Iga Jeziorska of Youth Organisations for Drug Action (YODA), Mat Southwell of European Network of People who Use Drugs (EuroNPUD), Maria Plotko of Eurasian Harm Reduction Association (EHRA) and Olga Belyaeva of Eurasian Network of People Who Use Drugs (ENPUD).

Enjoy listening to their conversation, and share your thoughts with us!

C-EHRN Podcast Series #2: Harm Reduction and Broader Development of Societies

Harm Reduction is not only a set of practices, strategies or approaches to support the needs of marginalised and underserved communities. As such, it is also a human rights movement for social justice. Moving away from responses that solely focus on individual [health] behaviours, harm reduction also brings attention to the impact of social determinants on health.

We talked to Tony Duffin of Ana Liffey Drug Project, Beatrix Vas of Youth Rise and Marta Borges of Social Emergency Unit, Portuguese Institute for Social Security. Following the opening session The Development of Drug Policy and Harm Reduction at the 5th European Harm Reduction Conference in Prague, we discussed advocacy, decriminalisation, and health inclusion, with our guests.

“We manage to be gatekeepers and not human rights services because we put so many questions to let people in that we end up keeping them out. This is the type of advocacy, we have been working on.” says Beatrix Vas.

“How we work with people and how we view people should be changed.” adds Tony Duffin.

And, Marta Borges tells us about how the situation has been like since the arrival of decriminalisation, the “holy-grail”, in her country, Portugal.

Enjoy listening and tell us what you think!

#HRAtWork #HarmReduction #EHRC21